Evidence map›Paper›PMID 38123239›Full record

Trial reportThe European respiratory journal2024

Oral nitrate supplementation improves cardiovascular risk markers in COPD: ON-BC, a randomised controlled trial.

Ali M Alasmari, Abdullah S Alsulayyim, Saeed M Alghamdi, Keir E J Philip, Sara C Buttery, Winston A S Banya, Michael I Polkey, Paul C Armstrong, Matthew J Rickman, Timothy D Warner and 2 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The European respiratory journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Ali M AlasmariNational Heart and Lung Institute, Royal Brompton Campus, Imperial College London, London, UK.
Abdullah S AlsulayyimNational Heart and Lung Institute, Royal Brompton Campus, Imperial College London, London, UK.
Saeed M AlghamdiClinical Technology Department, Umm Al-Qura University, Makkah, Saudi Arabia.
Keir E J PhilipNational Heart and Lung Institute, Royal Brompton Campus, Imperial College London, London, UK.
Sara C ButteryNational Heart and Lung Institute, Royal Brompton Campus, Imperial College London, London, UK.
Winston A S BanyaNational Heart and Lung Institute, Royal Brompton Campus, Imperial College London, London, UK.
Michael I PolkeyNational Heart and Lung Institute, Royal Brompton Campus, Imperial College London, London, UK.
Paul C ArmstrongCentre for Immunobiology, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
Matthew J RickmanNational Heart and Lung Institute, Cardiothoracic Pharmacology, Vascular Biology, Imperial College London, London, UK.
Timothy D WarnerCentre for Immunobiology, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID 0000-0003-3988-4408
Jane A MitchellNational Heart and Lung Institute, Cardiothoracic Pharmacology, Vascular Biology, Imperial College London, London, UK.
Nicholas S HopkinsonNational Heart and Lung Institute, Royal Brompton Campus, Imperial College London, London, UK n.hopkinson@ic.ac.uk.ORCID 0000-0003-3235-0454
Royal Brompton Hospital · GBHarefield Hospital · GBLung Institute · USQueen Mary University of London · GBTaibah University · SAUmm al-Qura University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundShort-term studies suggest that dietary nitrate (NO

methodsThe ON-BC trial was a randomised, double-blind, placebo-controlled parallel group study in stable COPD patients with home systolic BP (SBP) measurement ≥130 mmHg. Participants were randomly allocated (1:1) using computer-generated, block randomisation to either 70 mL NR-BRJ (400 mg NO

resultsCompared with placebo, active treatment lowered SBP (Hodges-Lehmann treatment effect -4.5 (95% CI -5.9- -3.0) mmHg), and improved 6MWD (30.0 (95% CI 15.7-44.2) m; p<0.001), RHI (0.34 (95% CI 0.03-0.63); p=0.03) and AIx75 (-7.61% (95% CI -14.3- -0.95%); p=0.026).

conclusionsIn people with COPD, prolonged dietary nitrate supplementation in the form of beetroot juice produces a sustained reduction in BP, associated with an improvement in endothelial function and exercise capacity.

Indexed as

Cardiovascular DiseasesPulmonary Disease, Chronic ObstructiveAntioxidantsBlood PressureCross-Over StudiesDietary SupplementsDouble-Blind MethodHumansNitratesRisk FactorsAntioxidantsNitrates

Identifiers

PMID38123239
PMCPMC10831142
OpenAlexW4390005403

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.